|
|
Tissue-Specific Mechanisms of Regulatory T Cells in the CNS during Autoimmune Encephalomyelitis |
| 1R01AI168063-01 |
|
NIAID |
2022 |
|
|
Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course |
| 1R01AI169070-01A1 |
|
NIAID |
2022 |
|
|
Metabolic regulators of Treg/Th17 balance in CNS autoimmunity |
| 1R01AI169075-01A1 |
|
NIAID |
2022 |
|
|
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots |
| 1R01AI169686-01 |
|
NIAID |
2022 |
|
|
Defining how TCR strength of signal modulates Treg function |
| 1R01AI169835-01A1 |
|
NIAID |
2022 |
|
|
Novel mouse models to dissect the role of genetics, sex, and environment in heterogeneous outcomes in CNS autoimmune disease |
| 1R01AI172166-01 |
|
NIAID |
2022 |
|
|
Regulation of the Microglial Neuroimmune Response by Long Non-Coding RNAs |
| 1R15AI156879-01A1 |
|
NIAID |
2022 |
|
|
Alu dsRNAs as adjuvants for influenza vaccines |
| 1R21AI164107-01A1 |
|
NIAID |
2022 |
|
|
Identification of cellular heme transport receptors that regulate T cell function |
| 1R21AI164722-01A1 |
|
NIAID |
2022 |
|
|
Combating chronic neuroinflammatory disorders by targeting NAC1 |
| 1R21AI167793-01A1 |
|
NIAID |
2022 |